Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Mar 23.
Published in final edited form as: J Nat Prod. 2012 Jan 30;75(3):473–478. doi: 10.1021/np200963r

An Endogenous Bile Acid and Dietary Sucrose from Skin Secretions of Alkaloid-Sequestering Poison Frogs

Valerie C Clark †,*, Liva Harinantenaina , Martin Zeller §, William Ronto , James Rocca , Aaron Dossey , Daniel Rakotondravony , David G I Kingston , Chris Shaw
PMCID: PMC3311751  NIHMSID: NIHMS350289  PMID: 22289087

Abstract

graphic file with name nihms350289f5.jpg

The skins of Madagascar poison frogs (Mantella) and certain Neotropical poison frogs (Epipedobates, Dendrobates) secrete the new bile acid tauromantellic acid (1), which was found in both wild-caught and captive-born frogs. This is the first molecule of endogenous origin detected in skin secretions from these taxa. Sucrose was also detected in secretions from wild-caught Mantella but not in captive-born frogs, suggesting a dietary origin.


Frog skins have proved to be a prolific source of secondary metabolites, and in particular over 800 different lipophilic alkaloids have been detected in skin extracts from six unrelated frog families from five continents.13 With few known exceptions, however,4, 5 these alkaloids are sequestered unchanged into the frogs’ granular skin glands from alkaloid-containing arthropod prey, and are thus not poison frog products. Relative to other families of such “tropical poison frogs”,6 Madagascar poison frogs (Mantella; Mantellidae) and several genera of neotropical dendrobatid poison frogs (Figure 1) contain the greatest variety of alkaloids in skin glands2, 711 and some of their alkaloid-containing arthropod prey have been identified.12 No other skin chemistry has yet been documented from these frog taxa.2, 13 This report documents the presence of the new bile acid tauromantellic acid (1) and sucrose in the skin secretions of these frogs. Tauromantellic acid (1) is the first example of a genuine poison frog metabolite from the skin of any tropical poison frog.

Figure 1.

Figure 1

Mantellid and dendrobatid poison frogs that provided skin secretions. (A) Mantella baroni. (B) Mantella betsileo. (C) Dendrobates auratus. (D) Epipedobates tricolor. Photograph credits: A, B, D by V. C. Clark; C by R. Skylstad.

RESULTS AND DISCUSSION

Skin secretions were obtained non-lethally from eight wild Mantella frogs, four each of Mantella baroni and Mantella betsileo. Analysis of these secretions by conventional positive ion GC-MS indicated the presence of several known alkaloids previously identified from a M. baroni secretion;7, 12 these are labeled (Figure 2A) with molecular weight codes as tabulated in Daly’s “frog alkaloid” mass spectroscopic library.2

Figure 2.

Figure 2

Orbitrap MS data acquired using a secretion sample collected from an individual wild Mantella baroni sample ‘Live Frog #3’ is shown here, and was replicated for other samples as seen in Figures S1–S11. (A) Positive ion mode total ion chromatogram (TIC) reveals peaks of previously identified alkaloids (see Refs.7,12). (B) Negative ion mode TIC contains a major peak representing tauromantellic acid. (C) Electrospray ionization (ESI) spectrum of the quasi-molecular ion [M+H]+ region of tauromantellic acid in positive ion mode. (D) ESI spectrum of the quasi-molecular ion region [M-H] of tauromantellic acid in negative ion mode.

MS analysis in negative ion mode gave a very different picture, and revealed the presence of a single major peak (Figure 2B) with composition C26H41NO6S, as determined by accurate mass measurements on in both positive and negative ion modes (Figure 2C,D). This novel compound was detected in each of the 11 frog skin secretion samples, as shown by TIC and ESI spectra (Table S1, Figures S1–S11, Supporting Information).

Sample manipulation in natural products chemistry can result in undesirable chemical modifications and even in total loss of some major components,14 demonstrating the value of direct analysis of unfractionated material.15 However, there are no reports of direct NMR spectroscopic analyses of unfractionated skin secretions from poison frogs. The technique of direct NMR analysis was thus applied to the skin secretions of Mantella spp., and this analysis indicated that the major constituent of the skin secretions was a bile acid. Purification of this major constituent was accomplished by pooling skin secretions from several frogs, leading to the isolation of compound 1.

The 1H NMR spectroscopic data of 1 (Table 1 and Figure S13, Supporting Information) showed signals for two angular methyl groups at δ 0.60 and 1.04 (each 3H, s), a methyl group on a double bond (δ 1.68, 3H, s), an oxygen-bearing methine (δ 3.81, 1H, m), a vinyl proton at δ 5.38 (1H, br t, J = 6.9 Hz), and two two-proton AB triplets of a taurine group at δ 3.58 and 2.94 (each 2H, t, J = 6.8 Hz). The 13C NMR signals generated from HMQC and HMBC experiments revealed the presence of 26 signals including those for a carbonyl group (δ 213.5), one oxygen bearing methine (δ 67.6) and an amide carbonyl group (δ 172.9). The above data coupled with the 1H- and 13C NMR data in Table 1 indicated that tauromantellic acid has a steroid skeleton with a ketone, a hydroxy group and an unsaturated side chain containing an amide group and the carbons of a taurine unit.

Table 1.

1H and 13C NMR Spectra (600 MHz and 151 MHz, respectively) for Tauromantellic Acid (1) from Captive-born Mantella betsileo, and for 7α-Hydroxycholestan-3-one in CD3OD.a,b,c

Carbon
No.
Proton
No.
δ, multiplicities,
Coupling (in Hz)
δ (ppm)
1d 7α-hydroxy-
cholestan-3-one
1 7α-hydroxy-
cholestan-3-one
C-1 Hax-1 1.39 m 1.38 m 39.5 39.6
Heq-1 2.04 m 2.04 m
C-2 Heq-2 2.23 br d (15) 2.23 brd (15) 38.3 38.9
Hax-2 2.48 td (14.6, 6.6) 2.48 td (14.6, 6.6)
C-3 - - - 213.5 214.7
C-4 Heq-4 1.93 dt (15, 2.7) 1.95 m 43.7 45.0
Hax-4 2.35 t (15) 2.36 t (15)
C-5 H-5 2.05 m 2.06 m 39.5 40.7
C-6 Heq-6 1.43 m 1.42 m 37.6 37.9
Hax-6 1.57 dt (14.5, 2.5) 1.57 m
C-7 H-7 3.81 m (w1/2 = 8.5) 3.79 q (2.5) 67.6 68.0
C-8 H-8 1.46 td (11.2, 2.5) 1.43 overlapped 41.0 41.9
C-9 H-9 1.32 overlapped 1.47 overlapped 46.2 46.5
C-10 - 35.0 36.8
C-11 Heq-11 1.62 overlapped 1.54 overlapped 22.1 22.3
Hax-11 1.42 m
C-12 Hax-12 1.20 m 2.05 overlapped 39.2 40.8
Heq-12 1.80 dt (12.8,3.3) 1.96 m
C-13 - - - 43.7 43.5
C-14 H-14 1.51 td (11.2, 4.7) 1.48 overlapped 49.9 51.7
C-15 Ha-15 1.23 m 1.14 m 24.2 24.5
Hb-15 1.83 m 1.75 m
C-16 Ha-16 1.69 br m 1.27 m 25.3 30.2
Hb-16 1.88 m 1.71 overlapped
C-17 H-17 2.13 t (9.4) 1.20 t (9.4) 58.7 57.4
C-18 CH3-18 0.60 s 1.06 s 13.3 10.6
C-19 CH3-19 1.04 s 1.05 s 10.4 10.6
C-20 - - - 139.1
C-21 CH3-21 1.68 s 18.2
C-22 H-22 5.38 br t (6.9) 117.3
C-23 Ha-23 2.98 d (6.9) 35.2
Hb-23 2.98 d (6.9)
C-24 - - 172.9
C-25 CH2-25 3.58 t (6.8) 35.3
C-26 CH2-26 2.94 t (6.8) 50.0
a

Data for 7α-hydroxycholestan-3-one were obtained on a sample kindly provided by Dr. B. S. Selinsky.

b

Assignments based on HMQC, COSY and HMBC spectra.

c

br: broad, m: multiplet, d: doublet, t: triplet, q: quadruplet, s: singlet.

d

Only peaks corresponding to the bile salt were observed in the NMR spectra; thus, the nature of this compound as a protonated species or as an anion is not yet clear.

The assignment of the ketone carbonyl to C-3, the hydroxy group to H-7, the taurine group to an amide bond at C-24, and the E configuration of the double bond were substantiated by analysis of the HSQC, COSY, HMBC and NOESY spectra. The COSY experiment (Figures S14–S15, Supporting Information) showed the spin systems H-1 to H-2; H-4, H-5, H-6, H-7, H-8, H-9, H-11, H-12; H-14, H-15, H-16, H-17; H-22, H-23; and H-25, H-26 (Figure 3A).

Figure 3.

Figure 3

(A) COSY correlations for 1. (B) NOESY correlations for 1.

The presence of three methyl groups in 1 was indicated by crosspeaks in its 1H-13C HSQC spectrum (Figures S16–S17, Supporting Information), and two of these resonated at δ 0.60 and 1.04 ppm, indicating the presence of two angular methyl groups characteristic of a steroid skeleton. The nature of the steroid skeleton and the stereochemistry of the A/B, B/C, and C/D ring junctions were indicated by a comparison of its 13C NMR signals with those of 7α-hydroxycholestan-3-one16 (Table 1) and by the interpretation of the NOESY spectroscopic data (Figures S18–S19, Supporting Information). The A/B, B/C, and C/D ring junctions were all deduced to be trans from the observation of NOESY correlations between CH3-19ax and H-1eq, H-4ax, H-6ax, and H-8ax, between H-5ax and H-4eq, H-6eq, and H-9, between H-9 and H-14, and between H-8 and CH3-18 and CH3-19. A correlation from the C-21 methyl group to CH3-18 assigned the R configuration to C-17. A clear NOESY correlation was observed from the proton at δ 5.38 (br t, H-22) to that of H-16β, allowing assignment of the E configuration to the double bond (Figure 3B). The axial orientation of the hydroxy group at C-7 was substantiated by the NOESY correlation between H-7eq (δ 3.81, m) and H-8ax (δ 1.46, td, J = 11.2, 2.5), and by the inferred coupling constant of 2.5 Hz between H-8ax and H-7eq.

The assignment of the AB ring junction of 1 as trans, instead of the more common cis stereochemistry for bile acids, was confirmed by a comparison of the NMR spectra of tauromantellic acid (1) with the spectra of the A and B rings of 7α-hydroxycholestan-3-one (Table 1).16 Both the 1H and 13C NMR signals of the A/B ring system of 1 agreed much better with the corresponding signals of 7α-hydroxycholestan-3-one than with those of 7α-hydroxy-24-nor-5β-cholan-3-one.17 In particular, the 1H NMR spectrum of 7α-hydroxy-24-nor-5β-cholan-3-one has a signal assigned to an H-4 proton at 3.39 ppm (t, J = 15);18 the H-4 protons in 1 resonate at 1.93 and 2.35 ppm and those in 7α-hydroxycholestan-3-one at 1.95 and 2.36 ppm (Table 1). The α-configuration of H-5 was supported by a NOESY correlation observed from H-6 axial (δ 1.57, td, J = 14.5, 2.5 Hz) and the C-19 methyl group (δ 1.04); such a correlation would not be possible if H-5 had the β-configuration. The large coupling constant observed for H-6 also supported this assignment. Finally, the 13C NMR chemical shift of the C-19 methyl in AB-trans-fused 3-keto-7α-hydroxy steroids appears around 10.4 ppm, while in the corresponding cis-fused series it appears between 12 and 22 ppm.18 A calculation of the 13C NMR shifts of both 1 and 5-epitauromantellic acid using commercially available software gave results in reasonably good agreement between the calculated and observed values for 1, while the calculated values for 5-epitauromantellic acid differed widely from the observed values for C-9 (calculated 33.2 ppm, observed 45.2 ppm) and C-19 (calculated 21.9 ppm, observed 10.4 ppm).

The site of amidation in 1 was assigned to C-24 (δ 172.9), based on the observation of HMBC cross-peaks from H-22 to C-24, H-23 (δ 2.98, d, 6.9 Hz) and from one of the methylene groups of taurine (δ 3.584, t, 6.8 Hz H-25) to C-24 (Figure S21, Supporting Information). Long-range correlations were observed in the HMBC spectrum from the C-21 methyl protons (δ 1.68) and C-17, C-22 and C-20 (Figure S22, Supporting Information), and from H-1 (δ 2.04), H-4 and H-5 to the ketone carbonyl at C-3 (Figure S23, Supporting Information).

The structure of the unsaturated taurine-conjugated side chain in 1 was confirmed by its detailed MS/MS fragmentation (Figure S12, Supporting Information). The structure of the new bile salt 1 was thus assigned as ((E)-4-((5S,7R,8R,9S,10S,13S,14S,17R)-7-hydroxy-10,13-dimethyl-3-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pent-3-enamido)methanesulfonic acid or 3-oxo-7α-hydroxy-5α-chol-20(22)-enoyltaurine, following bile acid nomenclature.19 The common name tauromantellic acid is assigned to this novel taurine-conjugated bile acid in honor of Mantella, the first poison frog genus in which the new compound has been detected.

In addition to its occurrence in wild specimens of Mantella baroni and M. betsileo, tauromantellic acid (1) was also detected in skin secretions collected from captive-born Mantella poison frogs, and from captive-born Dendrobates and Epipedobates spp. Wild dendrobatids were not sampled (Table 2).

Table 2.

Occurrence of Tauromantellic Acid (1), Sucrose, and Various Alkaloids in Samples Collected from Frogs Living in the Wild in Madagascar and from Captive-bred Frogs.

poison frog species sample
sizea
source 1 sucrose alkaloids
Mantella baroni 4 SE Madagascar + + +
Mantella betsileo 4 NW Madagascar + + +
Mantella betsileo 4 captive-bred +
Mantella betsileo 6 captive-bred +
Dendrobates auratus 7 captive-bred +
Epipedobates tricolor 1 captive-bred +
a

Wild frog secretions were analyzed individually, whereas captive-bred frog secretions were pooled. Sample collection, purification, and analysis are detailed in the Supporting Information.

In addition to tauromantellic acid (1), sugars were detected and sucrose was identified by 2D-NMRspectroscopic methods in skin secretions collected from Mantella poison frogs living in Madagascar rainforests, but sugars were not detected in any of the captive-born poison frogs (Table 2), thus suggesting a dietary origin of sucrose within the habitat of the frogs. As seen in the HSQC spectra of each of the eight individual wild Mantella, similar amounts of sucrose and tauromantellic acid were detected in concentrations greater than that of the dietary skin alkaloids of the frogs (Figure 4, Figures S24–S25, Supporting Information). It appears that additional sugars were present in amounts too minute to permit their identification.

Figure 4.

Figure 4

HSQC spectrum of skin secretions of one individual Mantella baroni frog. The signals from the HSQC spectrum of a sucrose standard are overlaid as red circles. This sample is referred to as “Live Frog #3” in reference 12. A larger version of this Figure is included as Figure S24 (Supporting Information).

The fact that the skins of Madagascar poison frogs (Mantella) and certain neotropical poison frogs (Epipedobates, Dendrobates) secrete the new bile acid tauromantellic acid (1) is significant. Although bile acids have been isolated and chemically characterized from the bile of most vertebrate taxa20 including several frog families2025 and their tadpoles,26 they have not been reported from frog skin secretions. In addition, unlike many of the alkaloids sequestered by poison frogs,2 1 must be an endogenous metabolite, since it is found in both wild and captive-bred frogs. It is interesting to speculate on the reason for the presence of this unusual bile acid in poison frog skin, and it is possible that this compound plays a key role in sequestering alkaloids and protecting the frogs from their own toxicity. Thus, tauromantellic acid (1) may form micelles that facilitate the uptake of alkaloids into the skin glands and subsequent storage, and it may also inhibit the precipitation of proteins by the basic alkaloids,27 perhaps by forming salts with them or sequestering them in micelles.

Sucrose, a sugar known only to be produced by plants and not by animals, was likely obtained indirectly via the diet of the frogs. Over half of the >600 contents previously identified from Mantella stomachs were ants of the genus Pheidole,12 the most abundant genus of ants in Madagascar. All above-ground foraging Pheidole ants, including over 100 species in Madagascar, tend honeydew-concentrating coccids (Hemiptera).28 Ants are well documented to obtain sucrose by tending to hemipterans that themselves acquire sugars from the phloem sap of their host plants.29, 30 Thus, considering the abundance of sugars in the diet of wild Mantella spp. and the lack of sucrose in the diet of captive-born Mantella spp., it appears that frogs in this genus sequester sucrose from ants that sequester it from hemipterans that sequester it from plants. These putative roles and the distribution of tauromantellic acid (1) and sucrose in amphibian skin secretions require further investigation.

The discovery of endogenous tauromantellic acid (1) and diet-sequestered sucrose in certain tropical poison frog skin secretions demonstrates that a non-lethal approach to frog skin secretion collection can result in particularly useful samples. Additonally, minimizing sample manipulation including the direct collection of secretion from living frogs31 combined with analysis via new combinations of modern technologies can reveal novel classes of compounds in amphibians that have already been studied in detail, even when only limited amounts of natural samples are available.

EXPERIMENTAL SECTION

General Experimental Procedures

The UV spectrum was measured on a Shimadzu UV-1201 spectrophotometer. 1H and 13C NMR spectra were recorded on Bruker 600 MHz spectrometers in CD3OD with TMS as internal standard. Calculated NMR shifts were obtained using ACD Laboratories Release 11.00; Product Version: 11.01. Mass spectra were acquired using LTQ Orbitrap XL or LTQ Orbitrap Velos instruments (Thermo Fisher Scientific, Bremen, Germany) operated in both negative and positive ion modes, as detailed in the Supporting Information. Preparative HPLC was performed using Shimadzu LC-10AT pumps coupled with a semi-preparative Varian Dynamax C18 column (5 µm, 250×10 mm), a Shimadzu SPD M10A diode array detector (DAD), and a SCL-10A system controller.

Sample Collection and Preparation

Poison frog secretion samples were collected in the field (Madagascar rainforests) and laboratory (captive-bred and born) by non-lethal methods in accordance with IACUC protocol 2006-0067 to V.C.C. at Cornell University31 which allowed the harvesting of skin secretions from living frogs. Wild Mantella species from Madagascar were sampled individually whereas captive-born Mantella species and secretions of dendrobatid poison frogs were pooled into one sample per species. In some cases, the secretion appeared as a milky substance on the skin surface, but was usually clear or invisible. As detailed in the Supporting Information, samples were collected by wiping skin secretions off their backs, both with and without electrical stimulation induced by a Transcutaneous Amphibian Stimulator (TAS).32 After each of two 10 sec stimulation events, their backs were wiped with MeOH-laced Kimwipes®,31 and these Kimwipes® were stored in tubes or vials until being filtered away as described in Supporting Information. After being wiped with MeOH, each frog was immersed in water and monitored for at least 10 min prior to release at point of capture. Frogs monitored in captivity were feeding, and in some cases calling, within 4 h of these sampling events.

Purification and Chemical Analyses

Filtered and dried secretion samples from wild Mantella spp. were used for the initial structural studies at the University of Florida, and additional captive-bred M. betsileo samples were used to purify about 1 mg of tauromantellic acid (1) at Virginia Tech. The secretions collected from six captive-born M. betsileo frogs were combined, and the material was purified by C18 reversed-phase HPLC at a flow rate of 2 mL/min and UV detection at 262 nm. The solvent system was a gradient starting with 50% MeOH in H2O containing 1% of HCOOH for 10 min, then from 50% to 90% MeOH over 10 min, from 90% to 100% MeOH over 5 min, concluding with 100% MeOH for 15 min. Approximately 1.0 mg of tauromantellic acid (1) was obtained, and was shown to be approximately 90% pure by 1H NMR spectroscopy.

Mass Spectrometry

A 2 µL sample of diluted extract was separated for each run via a Surveyor MS pump plus LC equipped with a MicroAS autosampler (all Thermo Fisher Scientific, San Jose, CA), using a Hypersil Gold column (C18 reversed-phase material, 1 mm inner diameter, 10 cm length, 1.9 µm particle size) at a flow rate of 50 µL/min. A gradient of 0 – 40% MeCN containing 0.1% HCOOH in 40 min followed by a wash step was used for analysis on the LTQ Orbitrap Velos. On the LTQ Orbitrap XL, a gradient of 0–30% MeCN containing 0.1% HCOOH in 18 min, a gradient of 30–70% MeCN from 18 to 22 min, and maintained at 70% MeCN until 26 min, followed by a wash step was used. The mass spectrometer performed a full MS scan with resolving power 30,000 full-width at half maximum at m/z 400, followed by six data-dependent HCD (higher energy collisional dissociation) MS/MS scans with resolving power 7,500 full width at half maximum at m/z 400. An Automatic Gain Control (AGC) target value of 1e6 ions was used for full FTMS survey scans and 1e5 ions for HCD MS/MS scans. The threshold for triggering MS/MS scans was set to 40,000 counts. Normalized collision energy was 37 eV with an activation time of 0.1 msec. ToxID 2.1.1 and XCalibur (Thermo Fisher Scientific) were used for data analysis and MassFrontier 6.0 (Thermo Fisher Scientific) was used to assign fragment ions.

NMR Spectroscopy

Dried samples were reconstituted in deuterated methanol (CD3OD) and analyzed by 1H NMR spectroscopy to determine which samples merited additional NMR experiments, as evidenced by signature methyl group signals (i.e. the C-18, C-19, and C-21 methyls, with shifts at 0.60, 1.04, and 1.68 ppm, respectively). Standard pulse sequences and methods were used to acquire 1D 1H spectra, 2D 1H/1H spectra (including, as appropriate, COSY, TOCSY, NOESY and ROESY experiments), and gradient-based 2D 1H/13C spectra (multiplicity-edited HSQC and magnitude-type HMBC experiments). These NMR experiments were performed on: (a) both unfractionated/crude and purified samples on a 600 MHz Bruker spectrometer at the VirginiaTech NMR facility, and (b) unfractionated/crude samples using a Bruker Avance-II-600 spectrometer equipped with a 5-mm CryoProbe™ at the AMRIS Facility of the University of Florida. At the AMRIS Facility, dried samples of the crude secretions were each reconstituted in 100 µl of 99.96% methanol-d4 (Cambridge Isotope Laboratories, Inc.), and those solutions were transferred to 2.5 mm × 100 mm capillary NMR tubes (Norell, Inc.) for data acquisition. The capillary tubes were suspended in the 5-mm probe using a Bruker MATCH™ device. All spectra were acquired at a regulated probe temperature of 24 °C. Chemical shift axes were referenced to the 1H and 13C solvent signals of HCD2OD. All spectra were analyzed using MNOVA software.

Tauromantellic acid (1)

White solid; [α]25D +23.3 (c 0.06, MeOH); UV (MeOH) end absorption only; 1H NMR (600 MHz, CD3OD), and 13C NMR (151 MHz, CD3OD), see Table 1 and Figure S13 (Supporting Information, 1H NMR only); positive ion HRESIMS m/z 496.2722 [M + H]+ (calcd for C26H42NO6S+, 496.2727); negative ion HRESIMS m/z 494.2576 [M + H] (calcd for C26H40NO6S+, 494.2582).

Supplementary Material

Supplementary Data

ACKNOWLEDGMENTS

Funding for field collection of frogs and their secretions in Madagascar was provided by the National Geographic Society Committee for Research and Exploration grant to V.C.C. and by National Science Foundation (NSF) grant DEB-9984496 to C. J. Raxworthy. Fieldwork in Madagascar was facilitated by the Madagascar Institute for the Conservation of Tropical Environments (MICET-ICTE), Madagascar National Parks (MNP; formerly ANGAP) and local communities at collection sites, Direction Generale des Eaux et Forêts (DEF), the California Academy of Sciences, and Valérie Rakotomalala. Fellowships and other funds to support VCC were generously provided by the School of Pharmacy at Queen’s University Belfast, the late Elizabeth E. Clark, and the NIH (to J. Meinwald GM 53830). J. Meinwald and F. Schroeder contributed to preliminary analysis of these samples with V.C.C. at Cornell University. NMR spectroscopy was supported by NIH ICBG grant U01 TW-00313 (to DGIK) and by the NSF under grant CHE-0619382 for purchase of the Bruker Avance 600 NMR spectrometer at Virginia Tech, and by the NSF-funded External User Program of the National High Magnetic Field Laboratory’s Advanced Magnetic Resonance Imaging and Spectroscopy (AMRIS) facility at the University of Florida. We thank Dr. B. S. Selinsky, Villanova University, for a generous gift of 7α-hydroxycholestan-3-one. Mass spectrometry was supported by Thermo Fisher Scientific and facilitated by M. Hornshaw. M. J. Mirabello, M. Pepper, and W. Huff kindly provided captive-bred Dendrobates auratus, Mantella betsileo, and Epipedobates tricolor, respectively. E. S. Chivian, G. M. Cragg and A.F. Hofmann are thanked for helpful comments on this manuscript.

Footnotes

ASSOCIATED CONTENT

Supporting Information

Experimental procedures detailing sample collection; Figures S1–S11, mass spectra of tauromantellic acid (1) detected in individual samples; Figure S12, product ion spectrum of tauromantellic acid (1); Figure S13–S23, NMR spectra of tauromantellic acid (1); Figures S24–S25, HSQC spectra of individual, wild Mantella poison frogs with overlay of sucrose standard; Table S1, exact measured masses of different tauromantellic acid (1) samples. This material is available free of charge via the Internet at http://pubs.acs.org:

REFERENCES

  • 1.Daly JW, Noimai N, Kongkathip B, Wilham J, Garraffo HM, Kaneko T, Spande TF, Nimit Y, Nabhitabhata J, Chan-Ard T. Toxicon. 2004;44:805–815. doi: 10.1016/j.toxicon.2004.08.016. [DOI] [PubMed] [Google Scholar]
  • 2.Daly JW, Spande TF, Garraffo HM. J. Nat. Prod. 2005;68:1556–1575. doi: 10.1021/np0580560. [DOI] [PubMed] [Google Scholar]
  • 3.Rodriguez A, Poth D, Schulz S, Vences M. Biol. Lett. 2010;7:414–418. doi: 10.1098/rsbl.2010.0844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Daly JW, Garraffo HM, Spande TF, Clark VC, Ma J, Ziffer H, Cover JF., Jr. Proc. Natl. Acad. Sci. U. S. A. 2003;100:11092–11097. doi: 10.1073/pnas.1834430100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Smith BP, Tyler MJ, Kaneko T, Garraffo HM, Spande TF, Daly JW. J. Nat. Prod. 2002;65:439–447. doi: 10.1021/np010506a. [DOI] [PubMed] [Google Scholar]
  • 6.Myers CW, Daly JW. Science. 1993;262:1193. doi: 10.1126/science.8235639. [DOI] [PubMed] [Google Scholar]
  • 7.Clark VC, Rakotomalala V, Ramilijoana O, Abrell L, Fisher BL. J. Chem. Ecol. 2006;32:2219–2233. doi: 10.1007/s10886-006-9144-6. [DOI] [PubMed] [Google Scholar]
  • 8.Daly JW, Andriamaharavo NR, Andriantsiferana M, Myers CW. Amer. Mus. Novit. 1996;3177:1–34. [Google Scholar]
  • 9.Daly JW, Myers CW, Whittaker N. Toxicon. 1987;25:1023–1095. doi: 10.1016/0041-0101(87)90265-0. [DOI] [PubMed] [Google Scholar]
  • 10.Daly JW, Witkop B, Bommer P, Biemann KJ. J. Am. Chem. Soc. 1965;87:124–126. doi: 10.1021/ja01079a026. [DOI] [PubMed] [Google Scholar]
  • 11.Neuwirth M, Daly JW, Myers CW, Tice LW. Tissue Cell. 1979;11:755–771. doi: 10.1016/0040-8166(79)90029-6. [DOI] [PubMed] [Google Scholar]
  • 12.Clark VC, Raxworthy CJ, Rakotomalala V, Sierwald P, Fisher BL. Proc. Natl. Acad. Sci. U. S. A. 2005;102:11617–11622. doi: 10.1073/pnas.0503502102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Erspamer V. In: Amphibian Biology. Heatwole G, Barthalmus T, Heatwole AT, editors. Vol. 1. Chipping Norton, UK: Surrey Beatty and Sons; 1994. pp. 178–350. [Google Scholar]
  • 14.Schroeder FC, Farmer JJ, Attygalle AB, Smedley SR, Eisner T, Meinwald J. Science. 1998;281:428–431. doi: 10.1126/science.281.5375.428. [DOI] [PubMed] [Google Scholar]
  • 15.Dossey AT, Walse S, Rocca JR, Edison AX. ACS Chem. Biol. 2006;1:512–514. doi: 10.1021/cb600318u. [DOI] [PubMed] [Google Scholar]
  • 16.Jones SR, Selinsky BS, Rao MN, Zhang X, Kinney WA, Tham FS. J. Org. Chem. 1998;63:3786–3789. [Google Scholar]
  • 17.Harris JM, Bolessa EA, Vederas JC. J. Chem. Soc. Perkin Trans. 1. 1995:1951–1959. [Google Scholar]
  • 18.Bettarello L, Bortolini O, Fantin G, Guerrini A. Il Farmaco. 2000;55:51–55. doi: 10.1016/s0014-827x(99)00121-4. [DOI] [PubMed] [Google Scholar]
  • 19.Hofmann AF, Sjovall J, Kurz ZR, Radominska A, Schteingart CD, Tint GS, Vlahcevic ZR, Setchell KD. J. Lipid Res. 1992;33:599–604. [PubMed] [Google Scholar]
  • 20.Hofmann AF, Hagey LR, Krasowski MD. J. Lipid Res. 2010;51:226–246. doi: 10.1194/jlr.R000042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Anderson IG, Haslewood GAD, Oldham RS, Amos B. Biochem. J. 1974;141:485–494. doi: 10.1042/bj1410485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Flury F. Arch. Exp. Pathol. Pharmakol. Physiol. Abstr. 1917;2:529. [Google Scholar]
  • 23.Hagey LR, Moller PR, Hofmann AF, Krasowski MD. Physiol. Biochem. Zool. 2010;83:308–321. doi: 10.1086/649966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kuramoto T, Kikuchi H, Sanemori H, Hoshita T. Chem. Pharm. Bull. 1973;21:952–959. doi: 10.1248/cpb.21.952. [DOI] [PubMed] [Google Scholar]
  • 25.Noma Y, Kihira K, Kuramoto T, Hoshita T. Steroids. 1998;51:385–394. doi: 10.1016/0039-128x(88)90026-8. [DOI] [PubMed] [Google Scholar]
  • 26.Anderson IG, Briggs T, Haslewood GAD, Oldham RS, Tokes L. Biochem. J. 1979;183:507–511. doi: 10.1042/bj1830507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Langecker H. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmakol. 1930;154:1–21. [PubMed] [Google Scholar]
  • 28.Fisher BL. In: The Natural History of Madagascar. Goodman SM, Benstead JP, editors. Chicago: University of Chicago Press; 2003. pp. 811–819. [Google Scholar]
  • 29.Delabie JHC. Neotrop. Entomol. 2001;30:501–516. [Google Scholar]
  • 30.Hölldobler B, Wilson EO. The Ants. Cambridge, MA: Belknap (Harvard University Press); 1990. p. 732. [Google Scholar]
  • 31.Clark VC. In: Behavioral and Chemical Ecology. Zhang W, Liu H, editors. New York: Nova Science Publishers Inc.; 2010. pp. 1–46. [Google Scholar]
  • 32.Grant JB, Land B. Herp. Rev. 2002;33:38–41. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Data

RESOURCES